Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count

Marion Divoux,Alexia Plocque,Margaux Sevin,Laurent Voillat,Pierre Feugier,Agnès Guerci‐Bresler,François Girodon,Julien Broséus

Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count

2020

Marion Divoux
Alexia Plocque
Margaux Sevin
Laurent Voillat
Pierre Feugier
Agnès Guerci‐Bresler
François Girodon
Julien Broséus

Lenalidomide is efficient in reducing red blood cell transfusion dependency and markedly lowering platelet counts in MDS/MPN-RS-T in the context of major platelet counts.

Keywords:

Medicine
Thrombocytosis
Lenalidomide
Pathology
Internal medicine
Oncology
Ring sideroblasts
Platelet

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations